NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
For Students
local_fire_department
Country Reports
person
Find a Professional
Joanna Przybyl
Stanford University - Stanford / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1669840
Registration, Add Profile,
Premium Membership
Get Your Global Impact Certificate
Ranking &
Analysis
Job
Experiences
Education
Information
Published Books
Book Chapters
Articles
Presentations
Lessons
Projects
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board
Patents /
Designs
Academic Grants
& Awards
Artistic
Activities
Certificate / Course
/ Trainings
Association &
Society Memberships
Contact, Office
& Social Media
person_outline
Joanna Przybyl's MOST POPULAR ARTICLES
1-)
Atlas of clinically distinct cell states and ecosystems across human solid tumors Cell 184 (21), 5482-5496. e28, 2021
2-)
Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas Journal of clinical oncology 31 (5), 608-615, 2013
3-)
BCOR internal tandem duplication in high-grade uterine sarcomas The American journal of surgical pathology 42 (3), 335-341, 2018
4-)
Identification of a novel, recurrent MBTD1‐CXorf67 fusion in low‐grade endometrial stromal sarcoma International journal of cancer 134 (5), 1112-1122, 2014
5-)
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis Clinical Sarcoma Research 9, 1-11, 2019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept